一般演題２１

[O21-1] 潰瘍性大腸炎患者に対するGUS導入療法の有効性：QUASAR第3相試験　前治療歴別評価

*藤井 俊光¹、Brian Bressler²、Laurent Peyrin-Biroulet³、Jessica R. Allegretti⁴、Kuan-Hsiang G. Huang⁵、Matthew Germinaro⁵、Nicole Shipitofsky⁵、Ye Miao⁵、Hongyan Zhang⁵、宮崎 由実⁶、Martin Bortlik⁷、Tibor Hlavaty⁸、Brian G. Feagan⁹、Bruce E. Sands¹⁰、Axel Dignass¹¹ (1. 東京医科歯科大学消化器内科、2. University of British Columbia, Vancouver, BC, Canada、3. Nancy University Hospital, Université de Lorraine, Nancy, France、4. Brigham and Women’s Hospital Crohn’s and Colitis Center, Boston, MA, USA、5. Janssen Research & Development, LLC, Spring House, PA, USA、6. ヤンセンファーマ株式会社メディカルアフェアーズ本部、7. Nemocnice České Budějovice, Ceske Budejovice, Czech Republic、8. Cliniq s.r.o, Bratislava, Slovakia、9. Alimentiv Inc, London, ON, Canada、10. Icahn School of Medicine at Mount Sinai, New York City, NY, USA、11. Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany)